Skip to main content
. 2017 Apr 21;4(2):21. doi: 10.3390/medicines4020021

Table 2.

The inhibition zones obtained testing the selected bacterial strains against the assayed EOs.

Bacterial Strains
Staphylococcus aureus Staphylococcus pseudointermedius Pseudomonas aeruginosa
Essential Oils
M SD M SD M SD
Anthemis nobilis 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Illicium verum 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Lavandula hybrida 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Litsea cubeba 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Ocimum basilicum 0.0 ± 0.0 7.0 ± 0.0 1 8.0 ± 0.0 2
Origanum vulgare 13.3 ± 0.6 3 17.3 ± 0.6 4 0.0 ± 0.0
Rosmarinus officinalis 0.0 ± 0.0 0.0 ± 0.0 7.0 ± 0.0 5
Salvia sclarea 0.0 ± 0.0 14.3 ± 0.6 6 8.0 ± 0.0 7
Thymus vulgaris 8.3 ± 0.6 8 0.0 ± 0.0 0.0 ± 0.0

Legend: M: mean expressed in mm; MIC: minimum inhibitory concentration; SD: standard deviation. 1 MIC: 18.34 µg/µL; 2 MIC: 18.34 µg/µL; 3 MIC: 2.36 µg/µL; 4 MIC: 1.18 µg/µL; 5 MIC: 18.28 µg/µL; 6 MIC: 2.23 µg/µL; 7 MIC: 17.86 µg/µL; 8 MIC: 18.73 µg/µL.

HHS Vulnerability Disclosure